Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Mold Inhibitor Market, by Type
1.4.2 North America Mold Inhibitor Market, by Application
1.4.3 North America Mold Inhibitor Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Mold Inhibitor Market by Type
4.1 North America Benzoates Market by Country
4.2 North America Sorbates Market by Country
4.3 North America Propionates Market by Country
4.4 North America Parabens Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Mold Inhibitor Market by Application
5.1 North America Pharmaceuticals Market by Country
5.2 North America Food & Beverage Market by Country
5.3 North America Animal Feed Market by Country
5.4 North America Cosmetics & Personal Care Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Mold Inhibitor Market by Country
6.1 US Mold Inhibitor Market
6.1.1 US Mold Inhibitor Market by Type
6.1.2 US Mold Inhibitor Market by Application
6.2 Canada Mold Inhibitor Market
6.2.1 Canada Mold Inhibitor Market by Type
6.2.2 Canada Mold Inhibitor Market by Application
6.3 Mexico Mold Inhibitor Market
6.3.1 Mexico Mold Inhibitor Market by Type
6.3.2 Mexico Mold Inhibitor Market by Application
6.4 Rest of North America Mold Inhibitor Market
6.4.1 Rest of North America Mold Inhibitor Market by Type
6.4.2 Rest of North America Mold Inhibitor Market by Application
Chapter 7. Company Profiles
7.1 DuPont de Nemours, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 BASF SE
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Eastman Chemical Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Kerry Group PLC
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Koninklijke DSM N.V.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 SWOT Analysis
7.6 Archer Daniels Midland Company
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Lanxess AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Kemin Industries, Inc.
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Corbion N.V.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 SWOT Analysis
7.10. Merck KGaA
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis
Unique Offerings 